Glial fibrillary acidic protein (GFAP) levels peak around 24 hours after traumatic brain injury (TBI) 2. Higher GFAP levels ...

A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent ...

Glial fibrillary acidic protein (GFAP), a blood biomarker, can be used to rapidly distinguish between hemorrhagic and ischemic stroke, according to a new prospective study. The hope, researchers say, ...

Neurofilament light chain and glial fibrillary acidic protein level increases were associated with cognitive decline in T2D with obesity.

Their findings, published in Brain Communications, suggest that GFAP could serve as a biomarker for stroke and brain injuries ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS ...

Results of a recent prospective study in Germany indicate that serum levels of the astrocytic glial fibrillary acidic protein (GFAP) could be used to differentiate between hemorrhagic and ischemic ...

This image shows Glial fibrillary acidic protein (GFAP) and Claudin-5 staining of an affected cell. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to ...

The test measures the levels of glial fibrillary acidic protein (GFAP), a protein specific to the brain which is released into the bloodstream when brain cells are damaged or destroyed.

Measuring blood levels of NfL, a biomarker of nerve damage, could help diagnose ALS and predict the risk of death for ...

As part of its focus on autoimmune disease, the company launched a multiple sclerosis monitoring profile in the fourth quarter of 2024 to monitor neurofilament light chain serum and GFAP values in ...

There are 4 immunoassays for neurofilament light chain that demonstrate consistent performance in patients with ALS.